brentuximab,nivolumab,ibrutinib,venetoclax
seagen,abbvie,roche,bms
['leukemia', 'cll', 'brentuximab', 'lymphoma', 'ibru', 'nivo', 'venetoclax', 'hodgkin']
brentuximab vs nivo in lh and ibrutinib + venetoclax in cll: the main topics at #asco23 for g. musuraca from do not loose the whole interview on and coming ! #chroniclymphociticleukemia #hodgkinlymphoma 
Latest research in hematology | Breaking news, insights, interviews, live tweeting and updates from major conferences. Co-published @ilpensiero | @think2it